Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
A quick evaluation of altcoin teams in 2024, focusing on development cadence, leadership experience, and past deliverables.
27,759 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
A niche battery company moved sharply higher as growth signals and product milestones drew investor attention. This a...
A veteran financial journalist breaks down abacus global (abx) 2025 Q4 results, explains what the numbers mean for 20...
When a public figure’s daughter is hurt in an e-bike crash, it’s a reminder that accidents touch every household. Thi...
Warner Bros Discovery's 2026 earnings call transcript offers more than quarterly figures. This analysis breaks down t...
Worries about the economy are common, especially when loans loom large. This guide breaks down practical steps you ca...
Tariffs often promise tax-bite relief while protecting jobs, but the math tells a different story. This guide explain...
NuScale Power faced a sharp February sell-off as project delays, funding needs, and analyst downgrades weighed on the...
A quiet, strategic move by a bank’s wealth management arm adds more exposure to its parent company’s stock. Learn wha...
When a heavyweight like SPGI outperforms in a quiet market, it often signals more than a single stock move. This piec...
A SpaceX AI push could rewrite how we think about tech bets. If spacex just spent billion, investors should watch how...
Bank of America finished the Fed stress tests without a dividend hike while peers boosted payouts. Here’s what the ba...